Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • News
  • Viewpoints
  • Product Updates
  • Community
  • Health Systems
  • Clinical
  • Topics
  • Job Board
MJH Life Sciences

SUBSCRIBE: Print / Digital / eNewsletter

Fear Motivates Vaccinations, New Study Finds

gloved hands holding syringe and vaccine vial
  • Jill Sederstrom
September 17, 2019
  • Vaccination and Immunization, Chains & Business, Community Practice, Health System News, The Latest

Fear can be a powerful force in determining whether adults are willing to get vaccinated during the threat of a possible outbreak, according to a new study in Heliyon. 

Researchers studied the public’s attitude about vaccines during the highly publicized outbreak of Ebola in Africa in 2014 to determine which factors impacted the public’s willingness to get a vaccine if a vaccine became available for Ebola. 

They found that fear—along with trust in the government to handle the crisis and the likelihood of exposure—were the leading factors in whether people were willing to get a vaccine.

“Facing a raising number of epidemics that create public health dangers, our findings indicate that vaccine hesitancy is associated with social factors that are independent of the perceived effectiveness of vaccines,” study investigator Kent P. Schwirian, PhD, said in a release announcing the findings. 

To evaluate the public’s attitudes about vaccination, researchers used survey data from a CNN/ORC poll in 2014 conducted over the phone. The findings included responses from 1,018 people across the United States.

Trending: Generics and Biosimilars Facing Formulary Difficulties

Based on the findings of the poll, about half of those surveyed said they would be willing to get vaccinated if an Ebola vaccine became available. 

Those with what researchers described as a “general fear orientation” who expressed fear not only of being infected but also more generally in terms of their outlook on life, were more willing to consider vaccination than those who didn’t report fears. According to the results of the study, more than 60 percent who reported being somewhat or very scared about events occurring in the United States were more willing to receive a vaccine.

Those people who expressed confidence in the United State’s ability to prevent an Ebola outbreak were also more willing to be vaccinated. 

Finally, even though 80 percent of those surveyed believed an outbreak in the United States was somewhat or highly likely, most believed it would not affect their own local community. Those who did believe an outbreak could occur near them, also reported a higher likelihood of getting vaccinated. 

Although the study centered on the now outdated fears associated with the Ebola outbreak, researchers said the study’s findings still could have important implications for today. 

Gustavo S. Mesch, PhD, another study investigator and professor of sociology and rector at the University in Haifa in Israel, said to appropriately prepare for a health crisis, local hospitals and health care professionals should know what percentage of the population would likely participate in vaccination attempts. 

“Confirming what percentage of the population would opt-in or out of vaccines, and the central role of trust in government, would help public officials plan their responses,” he said in the release. 

Read More: Understnading and Treating Postherpetic Itch

He recommended re-examining the research questions used in the study with more current data. 

According to the Centers for Disease Control and Prevention, the Ebola outbreak began in West Africa in 2013 when the first case was reported in a small village in Guinea. Two and a half years after that initial case, the outbreak ended with more than 28,600 cases and a total of 11,325 deaths.

Its impact on the United States was much smaller, with just 11 people overall treated in the United States after being exposed overseas.

Related Articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Surgical Care
  • Solid Tumors
  • COPD Management
  • Vaccination and Immunization
  • Non-Hodgkin Lymphoma
The Future of Pharmacy
Best Practices in Workflow Management for Retail Pharmacies
Hospital Pharmacy Technician Handbook
Rapid Credit Handbook
How to Accurately Determine True Drug Costs

Current Issue

Drug Topics November 2019
Nov 12, 2019 Vol 163 No 11
Digital Edition
Connect with Us

  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".